Markets

Bayer challenges $275 million US jury verdict on PCB injury claims

Bayer challenges 5 million US jury verdict on PCB injury claims

FRANKFURT (Reuters) – Germany’s Bayer Inc said on Friday it plans to legally challenge a jury ruling awarding $275 million to a group of people who claim they have suffered exposure to polychlorinated biphenyls, a chemical used by Bayer. Monsanto (NYSE 🙂 The works were produced until 1977.

Bloomberg and other media outlets reported Thursday the ruling in the King County Superior Court in the U.S. state of Washington in favor of 13 plaintiffs who blame their illnesses on exposure to polychlorinated biphenyls, or PCBs, at Sky Valley School in Monroe County.

“We respectfully disagree with the divided jury verdict reached in this case of 13 plaintiffs and plan to pursue post-trial appeals and appeals based on multiple errors and lack of evidence at trial,” Germany’s Bayer said in a statement.

“The uncontested evidence in this case does not support the conclusions that the plaintiffs were exposed to unsafe levels of PCBs at the Sky Valley Education Center or that these exposures are responsible for their alleged health problems,” she added.

Bayer shares were down 0.9% at 0738 GMT while Germany’s blue-chip index rose 0.7%.

While Monsanto’s herbicide report has been a much bigger burden for Bayer, the diversified health care and agriculture company is also trying to resolve PCB-related lawsuits. The chemical was used in commercial products until Monsanto voluntarily ended production in 1977.

Since 2020, Bayer has resolved the majority of cases in lawsuits with municipalities over PCB-contaminated wastewater for $650 million, but several other claims remain pending.

In August, it set aside €694 million for an expected settlement with the state of Oregon over PCBs in wastewater.

The combination of materials was once used in electrical equipment, carbonless copy paper, caulking, flooring finishes, and coatings. It was banned by the US government in 1979 after it was linked to cancer.

READ ALSO :   Amazon plans to close several US call centers - Bloomberg News

The Latest

To Top